Patient Guide: Clinical Trial of TQB3002 in Patients With Advanced Cancers

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06662760
Status: 🟢 Enrolling Now
Condition: Advanced Cancer
Phase: PHASE1

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Guangzhou, Guangdong
  • • Shenzhen, Guangdong
  • • Zhengzhou, Henan
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Trial of TQB3002 in Patients With Advanced Cancers - Join Clinical Trial NCTNCT06662760

How to Join This Clinical Trial - NCTNCT06662760

Learn how to participate in this PHASE1 trial studying an investigational therapy for Advanced Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06662760 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Guangzhou, Guangdong 510180 - China

Status: RECRUITING

Clinical Research Site

Shenzhen, Guangdong 518117 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Zhengzhou, Henan 450003 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210029 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanchang, Jiangxi 330038 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Shanghai, Shanghai Municipality 200000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Xi’an, Shanxi 710004 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Xi’an, Shanxi 710061 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Chengdu, Sichuan 610040 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Mianyang, Sichuan 621099 - China

Status: NOT_YET_RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Advanced Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships